These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 21671019

  • 21. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R.
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [Abstract] [Full Text] [Related]

  • 22. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage.
    Zhang B, Dhillon S, Geary I, Howell WM, Iannotti F, Day IN, Ye S.
    Stroke; 2001 Sep; 32(9):2198-202. PubMed ID: 11546917
    [Abstract] [Full Text] [Related]

  • 23. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N, Ostojić S, Volk M, Kapović M, Peterlin B.
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [Abstract] [Full Text] [Related]

  • 24. Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results.
    Roehe AV, Frazzon AP, Agnes G, Damin AP, Hartman AA, Graudenz MS.
    Breast Cancer Res Treat; 2007 Mar; 102(1):123-4. PubMed ID: 17260100
    [No Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis.
    Rech TF, Moraes SB, Bredemeier M, de Paoli J, Brenol JC, Xavier RM, Chies JA, Simon D.
    Genet Mol Res; 2016 Dec 19; 15(4):. PubMed ID: 28002595
    [Abstract] [Full Text] [Related]

  • 26. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T.
    J Soc Gynecol Investig; 2006 Apr 19; 13(3):232-6. PubMed ID: 16638593
    [Abstract] [Full Text] [Related]

  • 27. [Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women].
    Shevchenko AV, Konenkov VI, Garbukov EIu, Stakheeva MN.
    Vopr Onkol; 2014 Apr 19; 60(5):630-5. PubMed ID: 25816670
    [Abstract] [Full Text] [Related]

  • 28. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    Padala C, Tupurani MA, Puranam K, Gantala S, Shyamala N, Kondapalli MS, Gundapaneni KK, Mudigonda S, Galimudi RK, Kupsal K, Nanchari SR, Chavan U, Chinta SK, Mukta S, Satti V, Hanumanth SR.
    PLoS One; 2017 Apr 19; 12(9):e0184448. PubMed ID: 28961241
    [Abstract] [Full Text] [Related]

  • 29. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H, Melki R, Boughaleb Z, El Harroudi T, Aissaoui S, Boukhatem N.
    BMC Cancer; 2018 Mar 15; 18(1):292. PubMed ID: 29544444
    [Abstract] [Full Text] [Related]

  • 30. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
    Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL.
    Am Heart J; 2007 Oct 15; 154(4):751-8. PubMed ID: 17893005
    [Abstract] [Full Text] [Related]

  • 31. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
    Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, Wang B, Fang CF, Xue YS, Shen WF.
    Clin Biochem; 2007 Dec 15; 40(18):1427-30. PubMed ID: 18028894
    [Abstract] [Full Text] [Related]

  • 32. The matrix metalloproteinase-21 gene 572C/T polymorphism and the risk of breast cancer.
    Shagisultanova EI, Novikova IA, Sidorenko YS, Marchenko GN, Strongin AY, Malkhosyan SR.
    Anticancer Res; 2004 Dec 15; 24(1):199-201. PubMed ID: 15015597
    [Abstract] [Full Text] [Related]

  • 33. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
    Lu Z, Cao Y, Wang Y, Zhang Q, Zhang X, Wang S, Li Y, Xie H, Jiao B, Zhang J.
    J Neurooncol; 2007 Oct 15; 85(1):65-73. PubMed ID: 17502998
    [Abstract] [Full Text] [Related]

  • 34. Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk.
    Dofara SG, Chang SL, Diorio C.
    Anticancer Res; 2020 Jul 15; 40(7):3619-3631. PubMed ID: 32620601
    [Abstract] [Full Text] [Related]

  • 35. MMP-9 genetic polymorphism may confer susceptibility to COPD.
    Jiang S, Yang ZH, Chen YY, He Z, Zhou Y, Gao Y, Zhang Q, Tan MQ.
    Genet Mol Res; 2016 Apr 25; 15(2):. PubMed ID: 27173221
    [Abstract] [Full Text] [Related]

  • 36. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
    Decock J, Paridaens R, Ye S.
    Clin Genet; 2008 Mar 25; 73(3):197-211. PubMed ID: 18177467
    [Abstract] [Full Text] [Related]

  • 37. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
    Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J.
    Gene; 2013 Mar 15; 517(1):65-71. PubMed ID: 23313298
    [Abstract] [Full Text] [Related]

  • 38. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
    Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Försti A.
    Breast Cancer Res Treat; 2007 May 15; 103(1):61-9. PubMed ID: 17033924
    [Abstract] [Full Text] [Related]

  • 39. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, Guo W, Wang N, Fang S.
    Gynecol Oncol; 2006 Apr 15; 101(1):92-6. PubMed ID: 16278009
    [Abstract] [Full Text] [Related]

  • 40. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT, Munusamy P, Loke SY, Koh GL, Wong ESY, Law HY, Yoon CS, Tan MH, Yap YS, Ang P, Lee ASG.
    Cancer Res; 2017 Oct 01; 77(19):5428-5437. PubMed ID: 28775167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.